Clin2
NCT06516055Possibly a fitNot yet recruiting

Study of S1B-408 for women with orgasm difficulty

Orgasmic Disorder

Part of Mental health clinical trials.

This study tests an experimental oral medication, S1B-408, to see if it improves orgasm function in women with orgasmic disorder. It may be a good option if you have trouble achieving orgasm and are looking for a potential new treatment.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
30 people
Ages
25 years to 60 years
Study type
Interventional

Who can take part

  • You are a woman between 25 and 60 years old.
  • You have had trouble reaching orgasm for at least a while, and this is your main sexual problem.
  • You are in a sexual relationship and have sex at least once a week.
  • Your partner is sexually healthy (or has treated erectile dysfunction) and is around at least half the time.
  • You do not masturbate to orgasm more than once a week.
  • You do not have severe health issues like uncontrolled diabetes, liver or kidney problems, or a history of seizures.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06651541Not yet recruiting· Phase 2
Study of BZ371A for women with sexual arousal disorder

This trial tests a new medication, BZ371A, to see if it can safely improve sexual arousal in women who have a hard time getting or keeping physical signs of arousal like lubrication or clitoral swelling. It is designed for women in a stable relationship who have had previous sexual experiences but now struggle with arousal, and who find this distressing.

Belo Horizonte
NCT06116045Recruiting· Phase 2
Study of BZ371A for women with sexual arousal disorder

This trial tests an investigational medication, BZ371A, to see if it can help women with Female Sexual Arousal Disorder (FSAD), a condition where they have trouble getting or keeping physical signs of arousal like lubrication and warmth. The study aims to find out if BZ371A is safe, effective, and well-tolerated.

Rio de Janeiro, Rio de Janeiro
NCT07413705Recruiting
Devices for depression and sexual health in menopause

This study tests two devices (BTL-699-2 and HPM-6000UF) to see if they can improve depression symptoms and sexual function in women going through menopause or perimenopause. It may help with mood and intimacy during this life stage.

Winter Garden, Florida
NCT06932302Recruiting
At-home electrical stimulation for female sexual function

This study tests a device that uses gentle electrical stimulation to improve sexual function in women. You can use it at home after being trained at the study center.

Ann Arbor, Michigan
NCT07596212Not yet recruiting· Phase 1/Phase 2
Testing a Drug to Help with Sexual Side Effects from Breast Cancer Treatment

This study tests whether a medication called bupropion can help women with hormone receptor-positive breast cancer who are taking aromatase inhibitors (drugs that block estrogen) but experiencing low sexual desire as a side effect. The goal is to see if this approach improves both tolerance to the cancer medication and quality of life.

Chicago, Illinois
NCT07303946Not yet recruiting
Deep brain stimulation for hard-to-treat OCD

This trial tests a treatment called deep brain stimulation (DBS) for OCD that hasn't improved with standard treatments. Small electrodes are placed in specific brain areas to see if they can reduce severe OCD symptoms.

Hear when a new Orgasmic Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.